drugset / Trial / NCT00912925
Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is being conducted to demonstrate the safety and clinical efficacy of Aldurazyme treatment in MPS I patients
Timeline
- Start
- 2000-12
- Primary completion
- 2001-09
- Completion
- 2001-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | laronidase | Protein / enzyme biologic | 0.58 mg/kg | Intravenous |
| Comparator | laronidase | Protein / enzyme biologic | 100 iu/kg | Intravenous |